Dr Mark R Grey
Qualifications: MD, FRCP(UK), FRCPath
Area of special interest: myeloma, amyloidosis, lymphoproliferative disorders, general haematology
Training: Qualified 1989 Manchester medical school, MRCP 1992, Leukaemia Research Fellow Manchester Royal Infirmary 1992 - 1994, MD Manchester University 2000, Manchester haematology training scheme FRCPath 2000
I have been a consultant in Blackpool since January 2014, having previously worked as a consultant in Bolton for over 10 years. The move to Blackpool was prompted by the need for a change and the interest of working in a tertiary centre allowing more specialised work including involvement with autologous stem cell transplantation and registrar training as well as the fact that Lancashire and the Fylde coast is a very attractive place and I grew up in this part of the UK. The service has excellent research centre which has allowed me to get involved with national and commercial trials not possible during my time in Bolton. The more recent collaborative work with Lancashire Teaching hospitals to create a new Lancashire Haematology Centre has been the next step in our continually improving and expanding the service as a whole and we have recruited many additional staff during this time which has been very interesting to be part of. My main subspecialist interest is myeloma, amyloidosis and other lymphoproliferative disorders in general but I also enjoy general haematology and blood film and bone marrow morphology.
Dr Seye Kolade
Qualifications: Bsc hons. Biochem, MBChB, MRCP, FRCPath
Position: Consultant Haematologist
Interests / subspecialty: Myeloid disorders/anticoagulation
Haematology training in London South West rotation
Appointed Consultant Haematologist in Blackpool in 2014
Dr MP Macheta
Dr Macheta graduated from Edinburgh University in 1987 and trained in Haematology in Leeds and Manchester. He has been a Consultant Haematologist in Blackpool since 2001, during which time he has been Chair of the Network Site-specific Group (NSSG), Chair of the Lancashire and South Cumbria Haematology Multidisciplinary Team Meetings (MDTs) and Programme Director for Stem Cell transplantation. His main interests are treatment of lymphoma, multiple myeloma and lymphoproliferative diseases.
Dr Paul Cahalin
Qualifications: MA MBBS MRCP FRCPath
Dr Cahalin graduated from Downing College Cambridge in 1993, before completing his clinical training at Guy’s and St Thomas’ Hospitals in London in 1996. He undertook his general medical training in the South West of England, before moving to Manchester to complete his specialist haematology training at the Manchester Royal Infirmary and the Christie Hospital.
Dr Cahalin's particular interests are in the treatment of myeloid disorders including acute leukaemia, myelodysplasia and chronic myeloid leukaemia. He is part of the myeloid team at Blackpool Teaching Trust that is responsible for the treatment of acute leukaemia for the Lancashire and South Cumbria Cancer Network, covering a population of 1.6 million people.
He has been heavily involved in the recruitment of patients to national clinical trials in acute leukaemia for over 10 years. He is a member of the NCRI AML Working Party, a national committee that run clinical trials in the treatment of acute leukaemia throughout the UK.
Dr Cahalin is originally from London but has lived in the North West for many years. Most of his spare time is spent with his wife and two children. His main interests include cycling, walking, open water swimming and learning Spanish.
Dr. Raisa Guerrero Camacho
Position: Consultant Haematologist
Interests/Sub speciality: Leading specialist in Chronic lymphocytic leukaemias.
Management of Chronic Lymphocytic leukaemia (C-CLL); Hairy Cell Leukaemia (HCL); T-cell large granular lymphocyte (LGL) leukaemia; T-cell-prolymphocytic leukaemia (T-PLL); Hodgkin and non-Hodgkin Lymphomas; Multiple Myeloma and Cell therapy in Lymphoproliferative disease.
Graduated first in her class, with honours, from the Oriente University in Venezuela in 2005. Went on to earn a place at La Paz University Hospital, a level 4 Hospital, in Madrid Spain, where she continued specialised training as a Haematologist Consultant, completing this training in 2012. While there she was actively involved with complex haemato-oncology conditions, stem cell therapy, blood bank, laboratory, coagulopathies and research. Moved to the UK in 2015 and worked in hospitals at different levels, gaining experience at different approaches. Started at Blackpool Victoria Hospital in 2017 where she sub specialised in lymphoproliferative disease. Having become one of the foremost experts in her field, there, she leads the management of Chronic Lymphocytic Leukaemia, doing leading research, and running clinical and commercial trials in the UK.
Thanks to her international background and wide level of experience, she offers her patients the most current, internationally accepted care, and is very approachable in her bed-side manner.
Dr Sharran Grey
Qualifications: DClinSci FRCPath
Job role: Haematology Consultant Clinical Scientist
Dr Grey joined the consultant team at Lancashire Haematology Centre in December 2019. Her specialist responsibilities are consultant lead for the haematology and transfusion laboratories, and consultant lead for Clinical Transfusion across Blackpool and Preston. She contributes to direct patient care providing diagnostic work-up of GP referrals and contributes to a joint obstetric haematology clinic.
She has trained and worked in the North West for 33 years. She has a strong focus on research and development. Her doctoral research was ‘Accelerated Blood Transfusion for Selected Patients’ for which she won an NHS England Chief Scientific Officer’s Award in 2017. She also developed and implemented a CE marked red cell dosage web app with a team of colleagues at her previous organisation.
She was appointed as a Working Expert for Transfusion-Associated Circulatory Overload for Serious Hazards of Transfusion in 2015. She has a special interest in pulmonary complications of transfusion and contributes to the advancement of this area at an international level.
She is also an associate lecturer at Manchester Metropolitan University. Sharran has a number of publications and is a regular contributor at regional and national transfusion forums.